Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innovex International (INVX) Cash & Equivalents (2016 - 2025)

Innovex International's Cash & Equivalents history spans 17 years, with the latest figure at $203.4 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 177.58% year-over-year to $203.4 million; the TTM value through Dec 2025 reached $203.4 million, up 177.58%, while the annual FY2025 figure was $203.4 million, 177.58% up from the prior year.
  • Cash & Equivalents reached $203.4 million in Q4 2025 per INVX's latest filing, up from $163.4 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $375.2 million in Q3 2021 to a low of $7.4 million in Q4 2023.
  • Average Cash & Equivalents over 5 years is $162.9 million, with a median of $131.6 million recorded in 2024.
  • Peak YoY movement for Cash & Equivalents: tumbled 97.19% in 2021, then soared 1102.54% in 2024.
  • A 5-year view of Cash & Equivalents shows it stood at $9.7 million in 2021, then decreased by 13.56% to $8.4 million in 2022, then decreased by 12.0% to $7.4 million in 2023, then skyrocketed by 889.44% to $73.3 million in 2024, then surged by 177.58% to $203.4 million in 2025.
  • Per Business Quant, the three most recent readings for INVX's Cash & Equivalents are $203.4 million (Q4 2025), $163.4 million (Q3 2025), and $68.8 million (Q2 2025).